BAM
EXAS

Byrne Asset Management’s Exact Sciences EXAS Stock Holding History

Byrne Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-25
Closed -$1.7K – 553
2024
Q3 		$1.7K Hold
25
– – ﹤0.01% 509
2024
Q2 		$1.11K Hold
25
– – ﹤0.01% 517
2024
Q1 		$1.73K Hold
25
– – ﹤0.01% 497
2023
Q4 		$1.89K Sell
25
-50
-67% -$3.28K ﹤0.01% 502
2023
Q3 		$5K Hold
75
– – ﹤0.01% 400
2023
Q2 		$7K Hold
75
– – ﹤0.01% 435
2023
Q1 		$5K Hold
75
– – ﹤0.01% 451
2022
Q4 		$3.71K Hold
75
– – ﹤0.01% 457
2022
Q3 		$2K Hold
75
– – ﹤0.01% 467
2022
Q2 		$3K Hold
75
– – ﹤0.01% 462
2022
Q1 		$5K Hold
75
– – ﹤0.01% 447
2021
Q4 		$6K Buy
+75
New +$6.62K ﹤0.01% 440

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Byrne Asset Management's EXAS Position: Q4 2024 in Review

Byrne Asset Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 25 shares — an estimated $1.7K sold.

Byrne Asset Management first reported a position in EXAS in Q4 2021 and held it in 12 quarters. The position peaked at $7K in Q2 2023. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Byrne Asset Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Byrne Asset Management sold 25 Exact Sciences shares in Q4 2024, an estimated $1.7K.
  • Byrne Asset Management first reported a position in Exact Sciences in Q4 2021 and held it in 12 quarters.
  • Byrne Asset Management's Exact Sciences position peaked at $7K in Q2 2023.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Byrne Asset Management's 13F filing for Q4 2024, filed 28 Jan 2025.